FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care

Main|Search|PHGKB






Last Posted: Dec 09, 2018

---

• Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: Poll
  D Thompson, US News, December 6, 2018
• FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
  FDA Press Release, December 4, 2018
• PreMedKB: an integrated precision medicine knowledgebase for interpreting relationships between diseases, genes, variants and drugs.
  Yu Ying et al. Nucleic acids research 2018 Nov
• The current state of sickle-cell trait: implications for reproductive and genetic counseling.
  Pecker Lydia H et al. Blood 2018 Nov
• Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy.
  Collins Kimberly S et al. Pharmacogenetics and genomics 2018 Nov
• Biomarkers in sepsis: towards precision medicine for the prevention of adverse outcomes.
  Montini Luca et al. Minerva anestesiologica 2018
• Empirical therapy or precision medicine for kidney stone formers in the '-omics' era?
  Gambaro Giovanni et al. Urolithiasis 2018 Nov
• Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine.
  Conway Jake R et al. Genome medicine 2018 Nov 10(1) 93
• Role of Academic Biobanks in Public-Private Partnerships in the European Biobanking and BioMolecular Resources Research Infrastructure Community.
  Hämäläinen Iiro et al. Biopreservation and biobanking 2018 Nov
• Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer.
  Leão Ricardo et al. Clinical genitourinary cancer 2018 Oct

more